Spots Global Cancer Trial Database for Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

Official Title: Pilot Biomarker Modulation Study of Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer

Study ID: NCT02278965

Conditions

Stage 0 Breast Carcinoma

Breast Neoplasms

Stage I Breast Carcinoma

Stage II Breast Carcinoma

Stage III Breast Carcinoma

Interventions

Metformin

Omega-3 fatty acids

Study Description

Brief Summary: The purpose of this study is to determine whether it is feasible to give a combination of Metformin and omega-3 fatty acids for one year to women with a history of early stage breast cancer. We will also evaluate whether the metformin and omega-3 fatty acids combination causes changes in breast tissue, blood, and mammograms.

Detailed Description: Metformin is a medication used to treat and prevent diabetes and omega-3 fatty acids has been shown to lower cholesterol and improve cardiovascular health. Research has shown that Metformin and omega-3 fatty acids may also be effective in preventing cancer. In this study, we want to find out what effects, good and/or bad, the Metformin and omega-3 fatty acids combination has on you and your risk of developing a new breast cancer.